SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-12-16 16:09
Tx date 2022-12-12 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$220,660
+21,826 vol
$10.11 each 		34,697
Filed 2022-08-26 18:06
Tx date 2022-08-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,100,000
-175,000 vol
$12.00 each 		50,000
Filed 2021-12-14 15:20
Tx date 2020-06-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
-65,000 vol 		0
Filed 2021-12-14 15:19
Tx date 2019-06-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
-65,000 vol
Filed 2021-12-14 15:14
Tx date 2019-06-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
-65,000 vol
Filed 2021-12-14 15:13
Tx date 2019-06-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
-195,000 vol 		65,000
Filed 2021-12-14 15:12
Tx date 2019-06-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
+195,000 vol
Filed 2021-12-14 15:06
Tx date 2019-06-25 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
38 - Redemption, retraction, cancellation, repurchase
+195,000 vol
Filed 2021-12-13 17:12
Tx date 2021-12-08 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$191,520
+12,871 vol
$14.88 each 		12,871
Filed 2021-12-13 17:11
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
DSU
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-31 08:44
Tx date 2021-08-27 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,825,090
-100,000 vol
$18.25 each 		225,000
Filed 2021-04-05 08:16
Tx date 2021-03-31 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-489,000
-25,000 vol
$19.56 each 		325,000
Filed 2021-04-02 07:49
Tx date 2021-03-30 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,000,200
-50,000 vol
$20.00 each 		350,000
Filed 2020-12-23 11:43
Tx date 2020-12-23 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,190,000
-70,000 vol
$17.00 each 		400,000
Filed 2020-11-20 16:36
Tx date 2020-11-19 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-892,500
-52,500 vol
$17.00 each 		470,000
Filed 2020-11-20 16:35
Tx date 2020-11-19 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,507,500
-147,500 vol
$17.00 each 		0
Filed 2020-11-13 14:46
Tx date 2020-11-09 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights 		$450,000
+45,000 vol
$10.00 each 		305,000
Filed 2020-11-13 12:37
Tx date 2020-11-09 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$758,550
+48,750 vol
$15.56 each 		502,996
Filed 2019-08-20 12:44
Tx date 2019-08-19 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$43,620
+3,000 vol
$14.54 each 		522,500
Filed 2019-06-11 10:34
Tx date 2019-06-07 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,661,144
+106,826 vol
$15.55 each 		454,246
Filed 2018-08-23
Tx date 2018-08-22 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$784,894
+94,112 vol
$8.34 each 		347,420
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		253,308
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Grosvenor Ventures Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		519,500
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		147,500
Filed 2018-03-14
Tx date 2018-03-12 		$HLS
HLS Therapeutics Inc. 		Gubitz, Gregory David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
00 - Opening Balance-Initial SEDI Report 		260,000
Filed 2017-04-28
Tx date 2012-06-27 		$BTI
biOasis Technologies Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-28
Tx date 2017-04-24 		$BTI
biOasis Technologies Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+125,000 vol 		775,000
Filed 2017-04-28
Tx date 2017-04-24 		$BTI
biOasis Technologies Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Rights
56 - Grant of rights
+30,000 vol 		30,000
Filed 2016-04-15
Tx date 2016-04-10 		$BTI
biOasis Technologies Inc. 		Gubitz, Gregory David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+175,000 vol 		650,000